Maryland Tech Journal
SEE OTHER BRANDS

Get your science and technology news from Maryland

Maryland Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Tech Journal.

Press releases published on August 18, 2025

The Crowley Company Named Zeutschel GmbH’s 2024–2025 Dealer of the Year

The Crowley Company Named Zeutschel GmbH’s 2024–2025 Dealer of the Year

FREDERICK, MD, UNITED STATES, August 18, 2025 /⁨EINPresswire.com⁩/ -- The Crowley Company (Crowley) is proud to announce they were honored as Zeutschel GmbH's 2024–2025 Dealer of the Year during the annual Zeutschel dealer meeting in Tubingen, Germany. …

Lentech Inc. Completes Transition to 100% Employee-Owned Company Through ESOP

Lentech Inc. Completes Transition to 100% Employee-Owned Company Through ESOP

ELKRIDGE, MD, UNITED STATES, August 18, 2025 /⁨EINPresswire.com⁩/ -- Lentech Inc., a leading provider of technology-enabled IT, cloud and cyber solutions, and space systems engineering and technical support services, today announced the successful …

BCR Cyber Launches New Artificial Intelligence Course to its Cybersecurity Training Programs

BCR Cyber Launches New Artificial Intelligence Course to its Cybersecurity Training Programs

Course Prepares Students to Understand and Operate AI-enabled Tools in Security Operations Centers BALTIMORE, MD, UNITED STATES, August 18, 2025 /⁨EINPresswire.com⁩/ -- BCR Cyber, a leading provider of comprehensive cybersecurity training and job …

PureTech Systems and Clear Align Partner to Deliver Advanced Autonomous Security and Command-and-Control for U.S. Air Force Tactical Security System

PureTech Systems and Clear Align Partner to Deliver Advanced Autonomous Security and Command-and-Control for U.S. Air Force Tactical Security System

PHOENIX, Aug. 18, 2025 (GLOBE NEWSWIRE) -- PureTech Systems®, a leader in AI-boosted geospatial video analytics and command-and-control solutions, announced its role in a joint effort with Clear Align to deliver a rapidly deployable perimeter security …

Opthea Provides Corporate Update

Opthea Provides Corporate Update

Successful DFA settlement reached Company with cash and cash equivalents of approximately USD20M Dr Fred Guerard, CEO, Tom Reilly, CFO, and Sujal Shah, Director, to step down Dr Jeremy Levin to continue as Chairman and to assume additional responsibilities …

Tevogen CEO Donates Personal Shares to Support Local Law Enforcement

Tevogen CEO Donates Personal Shares to Support Local Law Enforcement

WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that its Founder and CEO, Dr. Ryan Saadi, has donated 10,000 of his personal shares of common stock to the Warren Township …

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand’s Addressable Market in the U.S. Milk Makeup Delivers Strong Retail Sales Performance in U.S. Retail in H1 2025 and Expands Its …

Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery

Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery

WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that Founder and CEO of Tevogen, Dr. Ryan Saadi, donated 10,000 of his personal shares of common stock to the Opportunity …

Hydreight Announces up to $10 Million Convertible Debenture Offering

Hydreight Announces up to $10 Million Convertible Debenture Offering

VANCOUVER, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), a leader in nationwide digital healthcare solutions, announces that it has entered into an …

Astrotech Corporation Appoints Nihanth Badugu as Chief Operating Officer

Astrotech Corporation Appoints Nihanth Badugu as Chief Operating Officer

AUSTIN, Texas, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”), today announced that it has appointed Nihanth Badugu as Chief Operating Officer (“COO”) of the Company. Mr. Badugu’s appointment is …

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, between August 4, 2025, and August 18, 2025, the Compensation …

Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)

Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA® (pemivibart) against XFG Centers for Disease Control data and wastewater surveillance data indicate XFG variant appears to be driving a growing wave of COVID-19 …

Eagle Pharmaceuticals Announces 2025 Annual Meeting Date

Eagle Pharmaceuticals Announces 2025 Annual Meeting Date

WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) will be held on October 17, 2025. The …

Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma

Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma

First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy SAN CARLOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a …

Diginex Announces 7 to 1 Stock-split paid as Bonus Shares

Diginex Announces 7 to 1 Stock-split paid as Bonus Shares

LONDON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (Nasdaq: DGNX) (the “Company”), today announced that its board of directors approved a seven-for-one forward stock split to be paid in the form of a share bonus. Each shareholder of the Company of …

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …

Snail, Inc. Announces Second Quarter 2025 Conference Call for Tuesday, August 19, 2025 at 4:30 p.m. ET

Snail, Inc. Announces Second Quarter 2025 Conference Call for Tuesday, August 19, 2025 at 4:30 p.m. ET

CULVER CITY, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, will hold a conference call and webcast on …

ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer

ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that …

iBio Announces Proposed Public Offering

iBio Announces Proposed Public Offering

SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced it has commenced an underwritten public offering (the “offering”) of (i) pre-funded warrants to purchase shares …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions